查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1451706

2024-2032 年按产品、技术（聚合酶炼式反应、微阵列、定序等）、应用、最终用户和地区分類的 DNA 甲基化市场报告

DNA Methylation Market Report by Product, Technology (Polymerase Chain Reaction, Microarray, Sequencing, and Others), Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3个工作天内

价格

2023年全球DNA甲基化市场规模达14亿美元。展望未来， IMARC Group预计到2032年市场规模将达到45亿美元，2024-2032年复合年增长率（CAGR）为13.5%。由于表观遗传学研究技术的不断进步、甲基化生物标记识别在疾病诊断中重要性的不断提升以及精准医疗产品应用的大幅增长，该市场正在经历稳定增长。

DNA甲基化市场分析：

市场成长与规模：在表观遗传学研究在了解疾病机制、推进精准医疗和确定潜在治疗标靶方面越来越多的采用的推动下，全球市场正在经历强劲成长。随着研究人员和产业认识到 DNA 甲基化分析的关键作用，市场规模正在扩大，涵盖诊断、製药和学术研究等不同领域的应用。

主要市场驱动因素：主要驱动因素包括对个人化医疗的需求不断增长、用于疾病诊断的 DNA 甲基化生物标记的识别以及药物发现中表观遗传学见解的整合。此外，慢性病的盛行率不断上升以及对先进诊断工具的需求也促进了市场的成长。

技术进步：高通量定序技术、微阵列平台和资料分析软体的不断进步，提高了DNA甲基化分析的效率和准确性。这些进步使研究人员能够探索复杂的表观遗传景观，有助于更深入地了解 DNA 甲基化模式及其对健康和疾病的影响。

产业应用：该产品广泛应用于各个产业，包括临床诊断、製药和生物技术研究以及学术研究。 DNA 甲基化分析是疾病检测、生物标记发现和药物开发的重要工具，促进其融入医疗保健、生命科学和生物医学研究的各个方面。

主要市场趋势：主要趋势包括定序技术的主导地位、基因治疗创新应用的出现以及对精准医疗的日益重视。市场正在见证向全面的全基因组分析的转变，使研究人员能够解开复杂的表观遗传机制并确定新的治疗标靶。

地理趋势：从地理上看，在先进的医疗基础设施、大量的研究投资和对基因组研究的关注的推动下，北美引领市场。在不断增加的医疗保健倡议和不断提高的个人化医疗意识的推动下，亚太地区正在见证显着的增长。欧洲仍然是重要的参与者，利用完善的研究基础设施和合作来推动 DNA 甲基化分析的进步。

竞争格局：竞争格局的特点是主要参与者在研发方面投入大量资金。公司正专注于开发创新技术、扩大产品组合併形成策略合作以保持竞争优势。该市场既有老牌企业，也有新兴企业，为不断变化的格局做出了贡献。

挑战与机会：挑战包括分析大规模表观基因组资料的复杂性、标准化方案的需求以及使用表观遗传资讯的伦理考量。然而，这些挑战为技术进步、标准化工作和道德准则的发展提供了机会，这可以进一步推动市场的成长。

未来展望：市场前景广阔，预计将持续成长。技术的不断进步、精准医学应用的增加以及表观遗传景观的不断探索预计将推动市场向前发展。我们将透过协作努力应对挑战，促进创新并扩大 DNA 甲基化分析跨不同产业整合的机会。

DNA 甲基化市场趋势：

表观遗传学研究进展

由于表观遗传学研究的不断进步，市场正在经历显着成长。研究人员和生物技术专家越来越多地阐明复杂的调控机制及其在各种生物过程中的影响，包括基因表现、细胞分化和疾病发展。新一代定序和高通量甲基化检测等尖端技术的可用性有助于在全基因组范围内对这些甲基化模式进行全面分析。随着我们对表观基因组的了解不断扩大，对先进甲基化分析工具和服务的需求不断增加，推动了市场的成长。

甲基化生物标记鑑定在疾病诊断中的重要性不断提高

DNA甲基化在基因表现调控中发挥着至关重要的作用，并与包括癌症在内的各种疾病的发生和进展密切相关。这些甲基化生物标记的鑑定已在疾病诊断、预后和治疗决策中发挥重要作用。人们越来越认识到这些甲基化特征是疾病状态的有价值的指标，从而推动了市场的发展。研究人员和临床医生正在利用这种甲基化分析来发现新的生物标记物，用于早期检测、监测治疗反应和开发个人化治疗干预措施，从而促进市场的扩张。

精准医疗领域的应用不断成长

采用根据患者独特的遗传和表观遗传特征为个别患者量身定制的精准医疗方法是市场的关键驱动力。 DNA 甲基化模式作为重要的表观遗传标记，影响疾病易感性、治疗反应和患者结果。随着精准医学在医疗保健领域的重要性日益凸显，甲基化分析成为表征患者特异性表观基因组变异不可或缺的一部分。此应用超出了肿瘤学范围，扩展到各种疾病，包括神经退化性疾病和心血管疾病。人们日益认识到个人化治疗策略可以显着改善患者的治疗效果，这刺激了对甲基化分析的需求，从而将市场定位在精准医学不断变化的领域的前沿。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球 DNA 甲基化市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品

  • 耗材
    • 市场走向
    • 市场预测
  • 试剂盒和试剂
    • 市场走向
    • 市场预测
  • 酵素
    • 市场走向
    • 市场预测
  • 仪器和软体
    • 市场走向
    • 市场预测

第 7 章：市场区隔：依技术

  • 聚合酶炼式反应 (PCR)
    • 市场走向
    • 市场预测
  • 微阵列
    • 市场走向
    • 市场预测
  • 定序
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：市场区隔：按应用

  • 基因治疗
    • 市场走向
    • 市场预测
  • 临床研究
    • 市场走向
    • 市场预测
  • 诊断
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按最终用户

  • 医院和诊断实验室
    • 市场走向
    • 市场预测
  • 製药和生物技术公司
    • 市场走向
    • 市场预测
  • 研究与学术界
    • 市场走向
    • 市场预测

第 10 章：市场区隔：按地区

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 11 章：驱动因素、限制与机会

  • 概述
  • 司机
  • 限制
  • 机会

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abcam plc.
    • Active Motif Inc.
    • Diagenode SA (Hologic Inc.)
    • EpiGentek Group Inc.
    • Illumina Inc.
    • Merck KGaA
    • New England Biolabs Inc.
    • PerkinElmer Inc.
    • Qiagen NV
    • Thermo-Fisher Scientific Inc.
    • Zymo Research Corporation
Product Code: SR112024A6890

The global DNA methylation market size reached US$ 1.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.5 Billion by 2032, exhibiting a growth rate (CAGR) of 13.5% during 2024-2032. The market is experiencing steady growth driven by the continual technological advancements in epigenetic research, the rising significance of methylation biomarker identification in disease diagnosis, and the considerable growth in product applications in precision medicine.

DNA Methylation Market Analysis:

Market Growth and Size: The global market is experiencing robust growth, driven by the increasing adoption of epigenetic research in understanding disease mechanisms, advancing precision medicine, and identifying potential therapeutic targets. As researchers and industries recognize the pivotal role of DNA methylation analysis, the market is expanding in size, encompassing applications across diverse sectors such as diagnostics, pharmaceuticals, and academic research.

Major Market Drivers: Key drivers include the rising demand for personalized medicine, the identification of DNA methylation biomarkers for disease diagnosis, and the integration of epigenetic insights in drug discovery. Additionally, the increasing prevalence of chronic diseases and the need for advanced diagnostic tools contribute to the market growth.

Technological Advancements: Continuous progress in high-throughput sequencing technologies, microarray platforms, and data analysis software enhances the efficiency and accuracy of DNA methylation analysis. These advancements enable researchers to explore the intricate epigenetic landscape, contributing to a deeper understanding of DNA methylation patterns and their implications in health and disease.

Industry Applications: The product finds extensive applications in various industries, including clinical diagnostics, pharmaceutical and biotechnology research, and academic studies. DNA methylation analysis serves as a valuable tool for disease detection, biomarker discovery, and drug development, fostering its integration into diverse facets of healthcare, life sciences, and biomedical research.

Key Market Trends: Key trends include the dominance of sequencing technologies, the emergence of innovative applications in gene therapy, and the growing emphasis on precision medicine. The market is witnessing a shift towards comprehensive genome-wide analysis, enabling researchers to unravel complex epigenetic mechanisms and identify novel therapeutic targets.

Geographical Trends: Geographically, North America leads the market, driven by advanced healthcare infrastructure, significant research investments, and a focus on genomic research. The Asia-Pacific region is witnessing notable growth, propelled by increasing healthcare initiatives and a rising awareness of personalized medicine. Europe remains a significant player, leveraging well-established research infrastructure and collaborations for advancements in DNA methylation analysis.

Competitive Landscape: The competitive landscape is characterized by key players investing heavily in research and development. Companies are focusing on developing innovative technologies, expanding their product portfolios, and forming strategic collaborations to maintain a competitive edge. The market showcases a mix of established players and emerging entrants, contributing to a changing landscape.

Challenges and Opportunities: Challenges include the complexity of analyzing large-scale epigenomic data, the need for standardized protocols, and ethical considerations in the use of epigenetic information. However, these challenges present opportunities for technological advancements, standardization efforts, and the development of ethical guidelines, which can further propel the market's growth.

Future Outlook: The future of the market appears promising, with sustained growth anticipated. Ongoing advancements in technology, increasing applications in precision medicine, and the continuous exploration of epigenetic landscapes are expected to drive the market forward. Challenges will be addressed through collaborative efforts, fostering innovation and expanding opportunities for the integration of DNA methylation analysis across diverse industries.

DNA Methylation Market Trends:

Advancements in epigenetic research

The market is experiencing significant growth due to continuous advancements in epigenetic research. Researchers and biotechnologists are increasingly unraveling the complex regulatory mechanisms and its implications in various biological processes, including gene expression, cellular differentiation, and disease development. The availability of cutting-edge technologies, such as next-generation sequencing and high-throughput methylation assays, facilitates comprehensive analysis of these methylation patterns at a genome-wide scale. As our understanding of the epigenome expands, the demand for advanced methylation analysis tools and services rises, driving the growth of the market.

Rising significance of methylation biomarker identification in disease diagnosis

DNA methylation plays a crucial role in the regulation of gene expression and is intricately involved in the development and progression of various diseases, including cancer. The identification of these methylation biomarkers has become instrumental in disease diagnosis, prognosis, and therapeutic decision-making. The market is propelled by the increasing recognition of these methylation signatures as valuable indicators of disease states. Researchers and clinicians are leveraging this methylation analysis to discover novel biomarkers for early detection, monitoring treatment responses, and developing personalized therapeutic interventions, thereby fostering the market's expansion.

Growing applications in precision medicine

The adoption of precision medicine approaches, tailored to individual patients based on their unique genetic and epigenetic profiles, is a key driver for the market. DNA methylation patterns serve as essential epigenetic markers that influence disease susceptibility, treatment responses, and patient outcomes. As precision medicine gains prominence in healthcare, methylation analysis becomes integral for characterizing patient-specific epigenomic variations. This application extends beyond oncology to various diseases, including neurodegenerative disorders and cardiovascular conditions. The growing realization that personalized therapeutic strategies can significantly improve patient outcomes fuels the demand for this methylation profiling, positioning the market at the forefront of the changing landscape in precision medicine.

DNA Methylation Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product, technology, application, and end user.

Breakup by Product:

Consumables

Kits and Reagents

Enzymes

Instrument and Software

Consumables account for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the product. This includes consumables, kits and reagents, enzymes, and instrument and software. According to the report, consumables represented the largest segment.

Breakup by Technology:

Polymerase Chain Reaction (PCR)

Microarray

Sequencing

Others

Sequencing holds the largest share of the industry

A detailed breakup and analysis of the market based on the technology have also been provided in the report. This includes polymerase chain reaction (PCR), microarray, sequencing, and others. According to the report, sequencing accounted for the largest market share.

Breakup by Application:

Gene Therapy

Clinical Research

Diagnostics

Others

Clinical research represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on the application. This includes gene therapy, clinical research, diagnostics, and others. According to the report, clinical research represented the largest segment.

Breakup by End User:

Hospital and Diagnostic Laboratories

Pharmaceutical and Biotechnology Companies

Research and Academia

Pharmaceutical and biotechnology companies represent the leading market segment

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospital and diagnostic laboratories, pharmaceutical and biotechnology companies, and research and academia. According to the report, pharmaceutical and biotechnology companies represented the largest segment.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest DNA methylation market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abcam plc.

Active Motif Inc.

Diagenode S.A. (Hologic Inc.)

EpiGentek Group Inc.

Illumina Inc.

Merck KGaA

New England Biolabs Inc.

PerkinElmer Inc.

Qiagen N.V.

Thermo-Fisher Scientific Inc.

Zymo Research Corporation

Key Questions Answered in This Report:

  • How has the global DNA methylation market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global DNA methylation market?
  • What is the impact of each driver, restraint, and opportunity on the global DNA methylation market?
  • What are the key regional markets?
  • Which countries represent the most attractive DNA methylation market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the DNA methylation market?
  • What is the breakup of the market based on the technology?
  • Which is the most attractive technology in the DNA methylation market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the DNA methylation market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the DNA methylation market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global DNA methylation market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global DNA Methylation Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Consumables
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Kits and Reagents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Enzymes
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Instrument and Software
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Polymerase Chain Reaction (PCR)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Microarray
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Sequencing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Gene Therapy
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Clinical Research
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Diagnostics
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospital and Diagnostic Laboratories
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Pharmaceutical and Biotechnology Companies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Research and Academia
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 Drivers, Restraints, and Opportunities

  • 11.1 Overview
  • 11.2 Drivers
  • 11.3 Restraints
  • 11.4 Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abcam plc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Active Motif Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Diagenode S.A. (Hologic Inc.)
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 EpiGentek Group Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Illumina Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Merck KGaA
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 New England Biolabs Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 PerkinElmer Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Qiagen N.V.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Thermo-Fisher Scientific Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Zymo Research Corporation
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: DNA Methylation Market: Major Drivers and Challenges
  • Figure 2: Global: DNA Methylation Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: DNA Methylation Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: DNA Methylation Market: Breakup by Product (in %), 2023
  • Figure 5: Global: DNA Methylation Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: DNA Methylation Market: Breakup by Application (in %), 2023
  • Figure 7: Global: DNA Methylation Market: Breakup by End User (in %), 2023
  • Figure 8: Global: DNA Methylation Market: Breakup by Region (in %), 2023
  • Figure 9: Global: DNA Methylation (Consumables) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: DNA Methylation (Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: DNA Methylation (Kits and Reagents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: DNA Methylation (Kits and Reagents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: DNA Methylation (Enzymes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: DNA Methylation (Enzymes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: DNA Methylation (Instrument and Software) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: DNA Methylation (Instrument and Software) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: DNA Methylation (Polymerase Chain Reaction (PCR)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: DNA Methylation (Polymerase Chain Reaction (PCR)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: DNA Methylation (Microarray) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: DNA Methylation (Microarray) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: DNA Methylation (Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: DNA Methylation (Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: DNA Methylation (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: DNA Methylation (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: DNA Methylation (Gene Therapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: DNA Methylation (Gene Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: DNA Methylation (Clinical Research) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: DNA Methylation (Clinical Research) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: DNA Methylation (Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: DNA Methylation (Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: DNA Methylation (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: DNA Methylation (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: DNA Methylation (Hospital and Diagnostic Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: DNA Methylation (Hospital and Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: DNA Methylation (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: DNA Methylation (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: DNA Methylation (Research and Academia) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: DNA Methylation (Research and Academia) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: North America: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: North America: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: United States: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: United States: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Canada: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Canada: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Asia-Pacific: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Asia-Pacific: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: China: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: China: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Japan: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Japan: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: India: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: India: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: South Korea: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: South Korea: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Australia: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Australia: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Indonesia: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Indonesia: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Others: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Others: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Europe: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Europe: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Germany: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Germany: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: France: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: France: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: United Kingdom: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: United Kingdom: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Italy: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Italy: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Spain: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Spain: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Russia: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Russia: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Others: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Others: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Latin America: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Latin America: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Brazil: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Brazil: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Mexico: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Mexico: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Others: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Others: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Middle East and Africa: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Middle East and Africa: DNA Methylation Market: Breakup by Country (in %), 2023
  • Figure 87: Middle East and Africa: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Global: DNA Methylation Industry: Drivers, Restraints, and Opportunities
  • Figure 89: Global: DNA Methylation Industry: Value Chain Analysis
  • Figure 90: Global: DNA Methylation Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: DNA Methylation Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: DNA Methylation Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: DNA Methylation Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: DNA Methylation Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: DNA Methylation Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: DNA Methylation Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: DNA Methylation Market: Competitive Structure
  • Table 8: Global: DNA Methylation Market: Key Players